Northern Trust Corp Jounce Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.9 - $1.85 $28,666 - $58,926	-31,852 Reduced 8.93%	324,786 $600,000
Q4 2022 Feb 13, 2023	BUY	$0.64 - $1.99 $15,028 - $46,729	23,482 Added 7.05%	356,638 $395,000
Q3 2022 Nov 14, 2022	SELL	$2.73 - $4.92 $153,218 - $276,130	-56,124 Reduced 14.42%	333,156 $779,000
Q2 2022 Aug 12, 2022	BUY	$2.8 - $7.67 $158,737 - $434,827	56,692 Added 17.05%	389,280 $1.18 Million
Q1 2022 May 13, 2022	SELL	$6.01 - $8.54 $84,945 - $120,704	-14,134 Reduced 4.08%	332,588 $2.26 Million
Q4 2021 Feb 08, 2022	SELL	$7.11 - $9.64 $27,906 - $37,837	-3,925 Reduced 1.12%	346,722 $2.89 Million
Q3 2021 Nov 15, 2021	SELL	$5.04 - $8.73 $389,279 - $674,287	-77,238 Reduced 18.05%	350,647 $2.61 Million
Q2 2021 Aug 13, 2021	BUY	$6.58 - $10.66 $1.15 Million - $1.87 Million	175,285 Added 69.39%	427,885 $2.91 Million
Q1 2021 May 12, 2021	SELL	$6.73 - $13.87 $410,799 - $846,624	-61,040 Reduced 19.46%	252,600 $2.59 Million
Q4 2020 Feb 11, 2021	BUY	$6.37 - $10.33 $25,919 - $42,032	4,069 Added 1.31%	313,640 $2.2 Million
Q3 2020 Nov 16, 2020	SELL	$4.58 - $10.95 $62,292 - $148,930	-13,601 Reduced 4.21%	309,571 $2.53 Million
Q2 2020 Aug 14, 2020	BUY	$4.17 - $7.58 $529,143 - $961,848	126,893 Added 64.65%	323,172 $2.23 Million
Q1 2020 May 14, 2020	BUY	$2.91 - $8.7 $68,926 - $206,068	23,686 Added 13.72%	196,279 $932,000
Q4 2019 Feb 14, 2020	SELL	$2.81 - $9.21 $22,940 - $75,190	-8,164 Reduced 4.52%	172,593 $1.51 Million
Q3 2019 Nov 13, 2019	SELL	$3.33 - $4.93 $28,657 - $42,427	-8,606 Reduced 4.54%	180,757 $602,000
Q2 2019 Aug 13, 2019	BUY	$4.3 - $6.73 $24,097 - $37,714	5,604 Added 3.05%	189,363 $937,000
Q1 2019 May 13, 2019	SELL	$3.43 - $6.87 $222 - $446	-65 Reduced 0.04%	183,759 $1.14 Million
Q4 2018 Feb 12, 2019	SELL	$2.69 - $6.71 $4,989 - $12,447	-1,855 Reduced 1.0%	183,824 $619,000
Q3 2018 Nov 14, 2018	BUY	$6.5 - $8.37 $158,093 - $203,575	24,322 Added 15.07%	185,679 $1.21 Million
Q2 2018 Aug 14, 2018	BUY	$7.27 - $21.88 $114,022 - $343,165	15,684 Added 10.77%	161,357 $1.24 Million
Q1 2018 May 09, 2018	SELL	$13.4 - $28.4 $60,460 - $128,140	-4,512 Reduced 3.0%	145,673 $3.26 Million
Q4 2017 Feb 14, 2018	BUY	$12.52 - $17.82 $70,187 - $99,898	5,606 Added 3.88%	150,185 $1.92 Million
Q3 2017 Nov 13, 2017	BUY	$11.17 - $16.99 $1.61 Million - $2.46 Million	144,579	144,579 $2.25 Million

Others Institutions Holding JNCE

# of Institutions

Shares Held

720K

Call Options Held

Put Options Held

View Full List

About Jounce Therapeutics, Inc.

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

More about JNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account